Haemonetics (HAE) Operating Income (2009 - 2026)
Haemonetics (HAE) posted quarterly Operating Income of -$23.0 million for Q1 2026, down 132.28% year-over-year from $71.3 million in Q1 2025, and down 134.16% quarter-over-quarter from $67.4 million in Q4 2025.
Haemonetics (HAE) Operating Income (2009 - 2026) Analysis & Trends
Haemonetics' Operating Income history runs 18 years deep, the most recent figure standing at -$23.0 million for Q1 2026.
- In Q1 2026, Operating Income fell 132.28% year-over-year to -$23.0 million; the TTM figure through Mar 2026 stood at $156.7 million (down 29.34% YoY), while the FY2026 annual figure was $156.7 million, down 29.34% from the prior year.
- Operating Income for Q1 2026 stood at -$23.0 million, down from $67.4 million in the prior quarter.
- The five-year high for Operating Income was $71.3 million in Q1 2025, with the low at -$23.0 million in Q1 2026.
- The 5-year median for Operating Income is $44.6 million (2022), against an average of $41.9 million.
- The sharpest annual moves came in 2022 and 2026: Operating Income surged 2113.45% in 2022, then sank 132.28% in 2026.
- Haemonetics' Operating Income stood at $43.3 million in 2022, then gained by 6.24% to $46.0 million in 2023, then grew by 28.39% to $59.0 million in 2024, then gained by 14.17% to $67.4 million in 2025, then tumbled by 134.16% to -$23.0 million in 2026.
- Business Quant data shows HAE's Operating Income at -$23.0 million in Q1 2026, $67.4 million in Q4 2025, and $58.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 196.58 Bn | 190.98 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 127.35 Bn | 123.88 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.25 Bn | 109.03 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 74.32 Bn | 73.78 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.26 Bn | 33.16 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 32.92 Bn | 30.82 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Smith & Nephew | 26.16 Bn | 25.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.91 Bn | 22.58 Bn | 4.55 Bn | 989.17 Mn |
| 10 | Haemonetics | 4.77 Bn | 4.55 Bn | 202.80 Mn | 57.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 57.46 Mn |
| Mar 28, 2026 | -23.03 Mn |
| Dec 27, 2025 | 67.40 Mn |
| Sep 27, 2025 | 58.49 Mn |
| Jun 28, 2025 | 53.87 Mn |
| Mar 29, 2025 | 71.34 Mn |
| Dec 28, 2024 | 59.03 Mn |
| Sep 28, 2024 | 51.70 Mn |
| Jun 29, 2024 | 39.76 Mn |
| Mar 30, 2024 | 29.94 Mn |
| Dec 30, 2023 | 45.98 Mn |
| Sep 30, 2023 | 35.30 Mn |
| Jul 1, 2023 | 53.66 Mn |
| Apr 1, 2023 | 35.26 Mn |
| Dec 31, 2022 | 43.28 Mn |
| Oct 1, 2022 | 46.73 Mn |
| Jul 2, 2022 | 30.77 Mn |
| Apr 2, 2022 | 19.20 Mn |
| Jan 1, 2022 | 35.65 Mn |
| Oct 2, 2021 | 24.51 Mn |